SCHEMBL7755648

SCHEMBL7755648

OC(CNc1ccccc1)CN1CCN(CC(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.55
DNM1 Q05193 2/20 0.52
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
OPRM1 P35372 1/20 0.48
OPRD1 P41143 1/20 0.48
MAPT P10636 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 1/20 0.46
CARM1 Q86X55 1/20 0.46
PRMT5 O14744 1/20 0.45
WDR77 Q9BQA1 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8616275 0.89 KDM1A (0.51) KDM1ADNM1MEN1KMT2AOPRM1
SCHEMBL8616272 0.88 KMT2A (0.64) KDM1ADNM1MEN1KMT2AOPRM1
SCHEMBL8617252 0.86 KDM1A (0.49) KDM1ADNM1MEN1KMT2AOPRM1
SCHEMBL3069013 0.82 KDM1A (0.55) KDM1ADNM1MEN1KMT2AMAPT
SCHEMBL7755959 0.81 SLC6A3 (0.50) KDM1AHTTKDM4E
SCHEMBL8371646 0.80 KDM1A (0.51) KDM1ADNM1MEN1KMT2AMAPT
SCHEMBL8371648 0.80 KDM1A (0.51) KDM1ADNM1MEN1KMT2AMAPT
SCHEMBL7754375 0.80 IGF1R (0.55) KDM1AMEN1KMT2AOPRM1OPRD1
Hydrochloric Acid SCHEMBL7543310 0.80 SLC6A3 (0.49) KDM1AHTTKDM4E
Hydrochloric Acid SCHEMBL7548578 0.79 IGF1R (0.54) KDM1AMEN1KMT2AOPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0706796-B1 DOPAMINE RE-UPTAKE INHIBITORS FOR THE TREATMENT OF PARKINSON'S SYNDROME POLA CHEM IND INC (JP) 2001-02-28 EP claimed
US-5747493-A N-/DIPHENYLALKYL/-PIPERAZINYL-2-HYDROXYPROPYLAMINES POLA CHEMICAL INDUSTRIES, INC. (JP) 1998-05-05 US claimed
EP-0706796-A1 DOPAMINE REINCORPORATION INHIBITOR POLA CHEMICAL INDUSTRIES, INC. (JP) 1996-04-17 EP claimed
EP-0549796-B1 DIPHENYLPIPERAZINE DERIVATIVE AND DRUG FOR CIRCULATORY ORGAN CONTAINING THE SAME POLA CHEM IND INC (JP) 1998-04-29 EP disclosed
US-5391552-A Has strong antagonism against calcium with less side effects POLA CHEMICAL INDUSTRIES, INC. (JP) 1995-02-21 US disclosed
EP-0612738-A1 Diphenylpiperazine derivative and drug for circulatory organ containing the same POLA CHEMICAL INDUSTRIES, INC. (JP) 1994-08-31 EP disclosed
EP-0549796-A1 DIPHENYLPIPERAZINE DERIVATIVE AND DRUG FOR CIRCULATORY ORGAN CONTAINING THE SAME POLA CHEMICAL INDUSTRIES INC (JP) 1993-07-07 EP disclosed